Boxplots and graphs.

<p>Neither last <b>(A)</b>, nor two-year mean <b>(B)</b>, HbA1c values differed between subjects with normal and impaired vibrotactile sense on at least one site on the foot. The duration of disease <b>(C)</b> did not statistically differ between subjects with normal and impaired vibrotactile sense on at least one site on the foot. However, among subjects with impaired vibrotactile sense, on at least one site of the foot, disease onset age was significantly higher <b>(D)</b>. The frequency of subjects with impaired vibrotactile sense, darker areas of the histograms, did not differ among boys and girls <b>(E)</b>, but subjects treated with MDI were more likely to have impaired vibrotactile sense <b>(F)</b>, than subjects treated with CSII. Among the 13 subjects with impaired vibrotactile sense four were receiving CSII treatment, and nine MDI treatment.